349 related articles for article (PubMed ID: 30083261)
1. Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics.
Zheng X; Zhang F; Zhao Y; Zhang J; Dawulieti J; Pan Y; Cui L; Sun M; Shao D; Li M; He K; Zhang M; Li J; Chen L
Theranostics; 2018; 8(14):3808-3823. PubMed ID: 30083261
[TBL] [Abstract][Full Text] [Related]
2. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
3. Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness.
Xie Y; Wang Y; Li J; Hang Y; Jaramillo L; Wehrkamp CJ; Phillippi MA; Mohr AM; Chen Y; Talmon GA; Mott JL; Oupický D
Theranostics; 2018; 8(16):4305-4320. PubMed ID: 30214622
[TBL] [Abstract][Full Text] [Related]
4. Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer.
Kim MW; Jeong HY; Kang SJ; Jeong IH; Choi MJ; You YM; Im CS; Song IH; Lee TS; Lee JS; Lee A; Park YS
Theranostics; 2019; 9(3):837-852. PubMed ID: 30809312
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
[TBL] [Abstract][Full Text] [Related]
6. In vivo visualization of endogenous miR-21 using hyaluronic acid-coated graphene oxide for targeted cancer therapy.
Hwang DW; Kim HY; Li F; Park JY; Kim D; Park JH; Han HS; Byun JW; Lee YS; Jeong JM; Char K; Lee DS
Biomaterials; 2017 Mar; 121():144-154. PubMed ID: 28088076
[TBL] [Abstract][Full Text] [Related]
7. siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy.
Xia Y; Guo M; Xu T; Li Y; Wang C; Lin Z; Zhao M; Zhu B
Int J Nanomedicine; 2018; 13():1539-1552. PubMed ID: 29588583
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
10. Turn-on theranostic fluorescent nanoprobe by electrostatic self-assembly of carbon dots with doxorubicin for targeted cancer cell imaging, in vivo hyaluronidase analysis, and targeted drug delivery.
Gao N; Yang W; Nie H; Gong Y; Jing J; Gao L; Zhang X
Biosens Bioelectron; 2017 Oct; 96():300-307. PubMed ID: 28511113
[TBL] [Abstract][Full Text] [Related]
11. From one to all: self-assembled theranostic nanoparticles for tumor-targeted imaging and programmed photoactive therapy.
Li X; Wang X; Zhao C; Shao L; Lu J; Tong Y; Chen L; Cui X; Sun H; Liu J; Li M; Deng X; Wu Y
J Nanobiotechnology; 2019 Feb; 17(1):23. PubMed ID: 30711005
[TBL] [Abstract][Full Text] [Related]
12. ATP-Responsive and Near-Infrared-Emissive Nanocarriers for Anticancer Drug Delivery and Real-Time Imaging.
Qian C; Chen Y; Zhu S; Yu J; Zhang L; Feng P; Tang X; Hu Q; Sun W; Lu Y; Xiao X; Shen QD; Gu Z
Theranostics; 2016; 6(7):1053-64. PubMed ID: 27217838
[TBL] [Abstract][Full Text] [Related]
13. Gene Therapy and Photothermal Therapy of Layer-by-Layer Assembled AuNCs /PEI/miRNA/ HA Nanocomplexes.
Yan LJ; Guo XH; Wang WP; Hu YR; Duan SF; Liu Y; Sun Z; Huang SN; Li HL
Curr Cancer Drug Targets; 2019; 19(4):330-337. PubMed ID: 30332960
[TBL] [Abstract][Full Text] [Related]
14. Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model.
Liang G; Zhu Y; Jing A; Wang J; Hu F; Feng W; Xiao Z; Chen B
Gene Ther; 2016 Dec; 23(12):829-838. PubMed ID: 27482839
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma.
Kunz M; Brandl M; Bhattacharya A; Nobereit-Siegel L; Ewe A; Weirauch U; Hering D; Reinert A; Kalwa H; Guzman J; Weigelt K; Wach S; Taubert H; Aigner A
J Nanobiotechnology; 2020 Nov; 18(1):173. PubMed ID: 33228711
[TBL] [Abstract][Full Text] [Related]
16. Redox Dual-Responsive and O
Chen H; Li F; Yao Y; Wang Z; Zhang Z; Tan N
Theranostics; 2019; 9(1):90-103. PubMed ID: 30662556
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic Acid Conjugated Magnetic Prussian Blue@Quantum Dot Nanoparticles for Cancer Theranostics.
Yang Y; Jing L; Li X; Lin L; Yue X; Dai Z
Theranostics; 2017; 7(2):466-481. PubMed ID: 28255343
[TBL] [Abstract][Full Text] [Related]
18. Anti-GPC3 Antibody Tagged Cationic Switchable Lipid-Based Nanoparticles for the Co-Delivery of Anti-miRNA27a And Sorafenib in Liver Cancers.
Wang Z; Zhao K; Zhang Y; Duan X; Zhao Y
Pharm Res; 2019 Aug; 36(10):145. PubMed ID: 31396764
[TBL] [Abstract][Full Text] [Related]
19. Targeting and Regulating of an Oncogene via Nanovector Delivery of MicroRNA using Patient-Derived Xenografts.
Sun S; Wang Y; Zhou R; Deng Z; Han Y; Han X; Tao W; Yang Z; Shi C; Hong D; Li J; Shi D; Zhang Z
Theranostics; 2017; 7(3):677-693. PubMed ID: 28255359
[TBL] [Abstract][Full Text] [Related]
20. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
